Tags:DesignPersonalPlatform
Neogene Therapeutics, Inc. is a biomedical company dedicated to developing next-generation T cell therapies that target mutated proteins (neo-antigens) in cancer. Neogene is developing a minimally invasive and scalable platform that will enable targeting of neo-antigens occurring in individual patients with fully personalized and genetically engineered “Designer T cells” that have been optimized to seek and destroy tumor cells based on neo-antigens.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 14.09.2020 | Series A | $110M | - | Neogene Th... |
Mentions in press and media 2